https://www.selleckchem.com/pr....oducts/orelabrutinib
Of them, 163 were excluded because of non-availability of all the variables. In total, 304 patients were studied. The prevalence of lymph node involvement was 15.8 % (48/304). In the crude and adjusted analysis, factors associated with lymph node involvement were lymphovascular invasion (adjusted OR 9.32; 95 % CI 4.27-21.15) and myometrial invasion (adjusted OR 3.95; 95 % CI 1.29-14.98). Of the patients undergoing lymphadenectomy, 15 % have lymph node involvement. Less invasive diagnostic options than radical surgery to ascertain
Me gusta
Comentario
Compartir
